Hypothalamic gene expression data from Mecp2-null and MECP2-transgenic mice
Ontology highlight
ABSTRACT: We compared gene expression changes in the hypothalamus of mice lacking MeCP2 (Mecp2-null) and mice overexpressing MeCP2 (MECP2-transgenic). Mutations in the gene encoding the transcriptional repressor methyl-CpG binding protein 2 (MeCP2) cause the neurodevelopmental disorder Rett syndrome. Loss of function as well as increased dosage of MECP2 gene cause a host of neuropsychiatric disorders. To explore the molecular mechanism(s) underlying these disorders, we examined gene expression patterns in the hypothalamus of mice that either lack or overexpress MeCP2. In both models, MeCP2 dysfunction induced changes in the expression levels of thousands of genes, but surprisingly the majority of genes (~85%) appeared to be activated by MeCP2. We selected six genes and confirmed that MeCP2 binds to
ORGANISM(S): Mus musculus
SUBMITTER: Maria Chahrour
PROVIDER: E-GEOD-11150 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA